Illumina will seek to cut $100 million in expenses by the end of this fiscal year as it plans to deal with a loss of revenue ...

The San Diego company also lowered its financial guidance for 2025 in response to China’s import restrictions.

Illumina’s NGS sequencers are used to sequence DNA or RNA samples and use a technology known as ... according to GlobalData’s ...

Illumina has been barred from exporting its DNA sequencers to China, which closed | Illumina has been barred from exporting ...

Brown Advisors, an investment management company, released its “Brown Advisors Global Leaders Strategy” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here. In the letter ...

The solutions – spanning genomics, spatial transcriptomics, single cell analysis ... today at the Advances in Genome Biology and Technology (AGBT) General Meeting. Illumina announced today ...

Illumina is not banned from operating in the country and will continue to serve its existing customers, a company ...

The latest job cuts at Illumina’s California headquarters are not part of a broad-based reduction, a company spokesperson ...

Illumina unveils first-of-its-kind spatial transcriptomics technology: San Diego Friday, February 21, 2025, 17:00 Hrs [IST] Illumina, Inc. announced a new spatial technology progr ...

Since purchasing Solexa with its Genome Reader instrument in 2007, Illumina’s continued innovation ... thinking of our people and exacting analysis of our research processes.

To streamline and to standardize the analysis of NGS data, we provide Perl scripts that can process data from all major platforms (Roche 454, Illumina Genome Analyzer and ABI SOLiD ...

Currently in early access, Illumina's 5-base solution for methylation analysis enables simultaneous genetic variant and methylation detection in a single assay. DNA methylation impacts how and ...